Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells

Virology

Volumn 376, Issue 2, 2008, Pages 290-296

  Ubol, Sukathida ^a   Chareonsirisuthigul, Takol ^a   Kasisith, Jitra ^a   Klungthong, Chonticha ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Research Institute of Medical Science   (Thailand)

Author keywords

cDNA array analysis; Dengue virus; Nitric oxide; NO; NS5 gene

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; RANTES; RNA POLYMERASE;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE VIRUS; DNA MICROARRAY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE FUNCTION; GENOTYPE; HOST CELL; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION STUDY; VIRUS ISOLATION;

AMINO ACID SEQUENCE; CELL LINE; CYTOKINES; DENGUE; DENGUE VIRUS; FREE RADICAL SCAVENGERS; GENE EXPRESSION PROFILING; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MONOCYTES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RNA REPLICASE; SEQUENCE ALIGNMENT; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

DENGUE VIRUS; DENGUE VIRUS GROUP;

EID: 44649150541     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.03.030     Document Type: Article

References (38)

1. Akira S., Taga T., and Kishimota T. Interleukin-6 in biology and medicine. Adv. Immunol. 54 (1993) 1-78
2. Ali S., Robertson H., Wain J.H., Isaaco J.D., Malik G., and Kirby J.A. A non- glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein 3) antagonizes chemokine-mediated inflammation. J. Immunol. 175 2 (2005) 1247-1266
3. Appay V., and Rowland-Jones S.L. RANTES: a versatile and controversial chemokine. Trends Immunol. 22 2 (2001) 83-87
4. Azizan A., Sweat J., Espino C., Gemmer J., Stark L., and Kayanis D. Differential proinflammatory and angiogenesis-specific cytokine production in human pulmonary endothelial cells, HPMEC-ST1.6R infected with dengue-2 and dengue-3 virus. J. Virol. Methods 138 1-2 (2006) 211-217
5. Balleotti F.G., Moreli M.L., and Figueiredo L.T.M. Brazilian Flavivirus phylogeny based on NS5. Men Inst. Oswaldo Cruz, Rio de Janeiro, 98 3 (2003) 379-382
6. Butrapet S., Huang CyH., Dierro D.J., Bhamarapravati N., Gubher D.J., and Kinney R.M. Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5′noncoding region and nonstructural proteins 1 and 3. J. Virol. 74 7 (2000) 3011-3019
7. Charnsilpa W., Takhumpanya R., Endy T.P., Mammer Jr. M.P., Libraty D.H., and Ubol S. Nitric oxide radical suppresses replication of wild-type dengue 2 viruses in vitro. J. Med. Virol. 77 1 (2005) 89-95
8. Cologna R., and Rico-Hesse R. American genotype structures decrease dengue virus out put from human monocytes and dendritic cells. J. Virol. 77 7 (2003) 3929-3938
9. Cologna R., Armstrong P.M., and Rico-Hesse R. Selection for virulent dengue virus occurs in human and mosquitoes. J. Virol. 79 2 (2005) 853-859
10. de la C Sierra B., Kouri G., and Guzman M.G. Race: a risk factor for dengue hemorrhagic fever. Arch. Virol. 152 3 (2007) 533-542
11. Fry T.J., and Mackall C.L. Interleukin 7: master regulator of peripheral T-cell homeostasis?. Trends Immunol. 22 10 (2001) 564-570
12. Green S., and Rothman A.L. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr. Opin. Infect. Dis. 19 5 (2006) 429-436
13. Hall T.A. Bio-Edit: a lesser-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Sym. Ser. 41 (1990) 55-58
14. Halstead S.B. Immunological parameters of togavirus disease syndromes. In: Schlesinger R.W. (Ed). The togaviruses, biology, structure, replication (1980), Academic Press, New York, New York, USA 107-175
15. Halstead S.B. Dengue virus-mosquito interactions. Annu. Rev. Entomol. 53 (2008) 273-291
16. Hartgring S.A., Bijlsma J.W., Lafeber F.P., and van Poon J.A. Interleukin-7 induced immunopathology in arthritis. Ann. Rheum. Dis. 65 suppl 3 (2006) iii69-iii74
17. Holmes E.C. The evolutionary biology of dengue virus. In New treatment strategies for dengue and other flaviviral diseases. Wiley, Chichester, Novartis Foundation Symposium 277 (2006) 177-192
18. Houng H.H., Hritz D., and Kanesa-thasan N. Quantitative detection of dengue 2 virus using fluorogenic RT-PCR based on 3′-noncoding sequence. J. Virol. Methods 86 1 (2000) 1-11
19. Huang Y.H., Lei H.Y., Liu H.S., Lin Y.S., Liu C.C., and Yeh T.M. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am. J. Trop. Med. Hyg. 63 1-2 (2000) 71-75
20. Kouri G., Guzman M.G., Valdes L., Carbonel I., del Rosario D., Vazquez S., Laferte J., Delgado J., and Cabrera M.V. Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg. Infect. Dis. 4 1 (1998) 89-92
21. Lee Y.-R., Ching-Yao S., Nan-Haw C., Wu-Wai L., Huan-Yao L., Chia-Lun C., Tsuey-Yu C., Shun-Hua C., Yee-Shin L., Trai-Ming Y., and HGsiao-Sheng L. Denuge viruses can infect human primary lung epithelial as well as lung carcinoma cells, and can also induced the secretion of IL-6 and RNATES. Virus Res. 126 1- 2 (2007) 216-225
22. Luthje K., Cramer S.O., Ehrlich S., Veit A., Steeg C., Fleischer B., Bonin A., and Breloer M. Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune competent CD4-positive T cells. Eur. J. Immunol 36 8 (2006) 2035-2045
23. Martin J., Collot-Teixerira S., McGregor L., and McGregor J.L. The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes. Curr. Pharm. Des. 13 17 (2007) 1751-1759
24. Middleton J., Patterson A.M., Gardner L., Sohmutz C., and Ashton B.A. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 100 12 (2002) 3853-3860
25. Napolitano L.A., Grant R.M., Deeks S.G., Schmidt D., deRosa S.C., Herzenberg D.A., Herndier B.G., Anderson J., and McCune J.M. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implication for T-cell homeostasis. Nat. Med. 7 1 (2006) 73-79
26. Nguyen T.H., Lei H.Y., Ngeugen T.L., Lin Y.S., Huang K.J., Le B.L., Lin C.F., and Yeh T.M. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J. Infect. Dis. 189 2 (2004) 221-232
27. Pang T., Cardosa M.J., and Guzman M.G. Of cascade and perfect stroms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol. Cell Biol. 85 (2007) 43-45
28. Rabablert J., Wasi C., Kinney R., Kasisith J., Pitidhammabhorn D., and Ubol S. Attenuating characgteristics of DEN-2 PDK53 in flavivirus-naïve peripheral blood mononuclear cells. Vaccine 25 19 (2007) 3896-3905
29. Rico-Hesse R., Harrison L.M., Salas R.A., Tovar D., Nisalak A., Ramos C., Boshell J., deMesa M.T., Nogueira R.M., and da Rosa A.T. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230 2 (1997) 244-251
30. Rodriguez-Roche R., Alvarez M., Gritsun T., Halstead S.B., Kouri G., Gould E.A., and Guzman M.G. Virus evolution during a severe dengue epidemic in Cuba, 1997. Virology 334 2 (2005) 154-159
31. Suksanpaisan L., Cabrera-Hernandez A., and Smith D.R. Infection of human primary hepatocytes with dengue virus serotype 2. J. Med. Virol. 79 3 (2007) 300-307
32. Tabavera D.L., Castillo A.M., Dominguez M.C., Gutierrez A.E., and Meza I. IL-8 release, tight junction and cytoskeleton dynamic reorganization conductive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J. Gen.Viorol. 85 Pt7 (2004) 1801-1813
33. Takhumpanya R., Padmanabhan P., and Ubol S. Antiviral action of nitric oxide on dengue virus type 2 replication. J. Gen. Virol. 87 Pt10 (2006) 3003-3011
34. Ubol S., Sukwattanapan C., and Utaisincharoen P. Rabies virus replication induced Bax-related, caspase dependent apoptosis in mouse neuroblastoma cells. Virus Res. 56 (1998) 207-215
35. Watts D.M., Porter K.R., Putavatana P., Vasquez B., Calampa C., Hayes C.G., and Hastead S.B. Failure of secondary infection with American genotype dengue 2 to casue dengue haemorrhagic fever. Lancet 354 9188 (1999) 1431-1434
36. World Health Organization. Dengue and dengue hemorrhagic fever. Fact sheet no. 117 (2002), World Health Organization, Geneva, Switzerland
37. Yap T.L., Xu T., Chen Y.-L., Malet H., Egloff M.-P., Canard B., Vasudevan S.G., and Lescar J. Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-Å resolution. J. Virol. 81 9 (2007) 4753-4765
38. Yoksan S., Bhamarapravati N., and Halstead B. Dengue virus vaccine development: study on biological markers of uncloned dengue 1-4 viruses serially passaged in primary kidney cells. In: George T.D., Kay B.H., and Blok J. (Eds). Arbovirus Research in Australia, Proceeding of the 4th Symposium CRIRO and Queensland Institute of Medical Research (1986) 35-38